{
    "eid": "2-s2.0-85079134341",
    "title": "Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy",
    "cover-date": "2020-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Orthopedics and Sports Medicine",
            "@code": "2732",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Physiology (medical)",
            "@code": "2737",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Adeno-associated virus",
        "Antisense oligonucleotide",
        "Combinatorial therapy",
        "Myostatin inhibition",
        "Myostatin propeptide",
        "Spinal muscular atrophy",
        "Survival of motor neuron 1 gene"
    ],
    "authors": [
        "Haiyan Zhou",
        "Jinhong Meng",
        "Alberto Malerba",
        "Francesco Catapano",
        "Palittiya Sintusek",
        "Susan Jarmin",
        "Lucy Feng",
        "Ngoc Lu-Nguyen",
        "Lianwen Sun",
        "Virginie Mariot",
        "Julie Dumonceaux",
        "Jennifer E. Morgan",
        "Paul Gissen",
        "George Dickson",
        "Francesco Muntoni"
    ],
    "citedby-count": 38,
    "ref-count": 51,
    "ref-list": [
        "Identification and characterization of a spinal muscular atrophy-determining gene",
        "A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy",
        "A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2",
        "Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model",
        "A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse",
        "A novel morpholino oligomer targeting ISS-N1 improves rescue of severe SMA transgenic mice",
        "Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy",
        "Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN",
        "Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy",
        "CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy",
        "Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy",
        "Therapeutic approaches for spinal muscular atrophy (SMA)",
        "Nusinersen versus sham control in infantile-onset spinal muscular atrophy",
        "Nusinersen versus sham control in later-onset spinal muscular atrophy",
        "Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member",
        "Regulation of myostatin activity and muscle growth",
        "Dominant negative myostatin produces hypertrophy without hyperplasia in muscle",
        "The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum",
        "Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression",
        "Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice",
        "Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa-guanidine morpholino oligomer treatment",
        "Dual myostatin and dystrophin exon skipping by morpholino nucleic acid oligomers conjugated to a cell-penetrating peptide is a promising therapeutic strategy for the treatment of Duchenne muscular dystrophy",
        "Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice",
        "Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice",
        "Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches",
        "Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy",
        "Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset",
        "A mouse model for spinal muscular atrophy",
        "Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response",
        "Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle",
        "Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy",
        "Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice",
        "Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy",
        "Activin receptor type IIB inhibition improves muscle phenotype and function in a mouse model of spinal muscular atrophy",
        "From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction",
        "Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy",
        "Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy",
        "A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein",
        "Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology",
        "The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation",
        "Reversible molecular pathology of skeletal muscle in spinal muscular atrophy",
        "Lack of myostatin alters intermyofibrillar mitochondria activity, unbalances redox status, and impairs tolerance to chronic repetitive contractions in muscle",
        "Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle",
        "Molecular mechanisms underlying sensory-motor circuit dysfunction in SMA",
        "Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy",
        "Myostatin-like proteins regulate synaptic function and neuronal morphology",
        "Axon and muscle spindle hyperplasia in the myostatin null mouse",
        "Genome-wide atlas of gene expression in the adult mouse brain",
        "Autoregulation of neurogenesis by GDF11",
        "Biochemistry and biology of GDF11 and myostatin: similarities, differences, and questions for future investigation",
        "Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019"
    ],
    "affiliation": [
        {
            "affiliation-city": "London",
            "@id": "60012662",
            "affilname": "UCL Great Ormond Street Institute of Child Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012662",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Egham",
            "@id": "60020595",
            "affilname": "Royal Holloway, University of London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020595",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "London",
            "@id": "60018207",
            "affilname": "Great Ormond Street Hospital for Children NHS Foundation Trust",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018207",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60013789",
            "affilname": "Beihang University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013789",
            "affiliation-country": "China"
        }
    ],
    "funding": [
        "Dubowitz Neuromuscular Centre",
        "National Health Service",
        "Wellcome Trust",
        "SMA Trust",
        "Muscular Dystrophy UK",
        "Biomedical Research Centre",
        "MRC",
        "National Institute for Health Research",
        "University College London",
        "Great Ormond Street Hospital for Children NHS Foundation Trust"
    ]
}